Editor's Note NDM-producing carbapenem-resistant Enterobacterales are climbing fast and straining treatment choices, according to a September 23 release from the Centers for Disease Control and Prevention (CDC) and published in the Annals of Internal Medicine. The agency warns NDM-CRE infections rose more than 460% in the US from 2019 to…